Praxis Precision Medicines PRAX
NASDAQ PRAX
$261.90 -2.58 (-0.98%)
As of: Oct 21, 2026 · 1:49 PM EDT

Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026)

Updated

Praxis Precision Medicines' Research & Development came in at $69.42 million for Q2 2026, up 10.2% from $63.01 million a year earlier but down 11.0% from the prior quarter.

Analysis

Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Praxis Precision Medicines reported Research & Development of $290.71 million, up 31.0% year-over-year; for FY2025, it was $267.12 million, up 75.3% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of 42.8% (FY2020 to FY2025).
  • Going back by year, Research & Development was $152.41 million in FY2024 (+75.7%), $86.77 million in FY2023 (-44.0%), $155.04 million in FY2022 (+28.9%) and $120.26 million in FY2021 (+167.4%).
  • The five-year range for quarterly Research & Development is $17.26 million (Q3 2023) to $77.99 million (Q1 2026).
  • Year-over-year, Research & Development has increased for ten consecutive quarters, with growth averaging 92.3% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q4 2024 (growth of 206.1%), and the weakest in Q1 2023 (a decline of 51.6%).
  • Business Quant data shows PRAX's Research & Development at $77.99 million (Q1 2026), $77.51 million (Q4 2025) and $65.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 3.65 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 2.34 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn 4.05 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn 1.76 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn 2.81 Bn
10 Praxis Precision Medicines 7.63 Bn 5.22 Bn - 69.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.42 Mn
Mar 31, 2026 77.99 Mn
Dec 31, 2025 77.51 Mn
Sep 30, 2025 65.80 Mn
Jun 30, 2025 63.01 Mn
Mar 31, 2025 60.81 Mn
Dec 31, 2024 56.29 Mn
Sep 30, 2024 41.88 Mn
Jun 30, 2024 27.26 Mn
Mar 31, 2024 26.98 Mn
Dec 31, 2023 18.39 Mn
Sep 30, 2023 17.26 Mn
Jun 30, 2023 25.61 Mn
Mar 31, 2023 25.50 Mn
Dec 31, 2022 28.33 Mn
Sep 30, 2022 30.44 Mn
Jun 30, 2022 43.62 Mn
Mar 31, 2022 52.65 Mn
Dec 31, 2021 43.51 Mn
Sep 30, 2021 33.14 Mn
API Access

Praxis Precision Medicines Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PRAX&period=max&api_key=YOUR_API_KEY